Cardinal Health Inc.
Cardinal Health Reports Q3 FY26 Results and Raises Outlook
Summary
Cardinal Health, Inc. reported a 11% increase in third-quarter fiscal year 2026 revenues to $60.9 billion. GAAP operating earnings decreased 30% to $509 million, while non-GAAP operating earnings increased 18% to $956 million. The company raised its fiscal year 2026 non-GAAP EPS guidance to a range of $10.70 to $10.80. Additionally, Cardinal Health completed an additional $250 million share repurchase, bringing the total year-to-date repurchase to $1.0 billion.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement